InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,745.37
(
0.40%
)
US TECH 100
19,593.20
(
0.83%
)
Dow Jones
42,175.11
(
0.62%
)
Brent Oil
70.95
(
-3.06%
)
Bitcoin
65,039.34
(
3.02%
)
Post# of 403545
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Relentless4ever

Send PM Follow Ignore
Followers 3
Posts 213
Boards Moderated 0
Alias Born 01/25/2012

Relentless4ever

Re: bloomvest post# 2059

Monday, 05/21/2012 11:32:27 AM

Monday, May 21, 2012 11:32:27 AM

Post# of 403545
From the PR and I also believe in the 10Q from Friday:

'Primary endpoints for the study will be safety and tolerable dosing levels for a future Phase 2 clinical trial.'

What about efficacy in Phase I as they've previously stated before? Does anyone have any thoughts in this area as to whether phase I is just exclusively safety and tolerable dosing levels? It would be nice if this is a potential break-thru drug that it could be fast-track through all phases of development.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!